VANCOUVER, BC, Aug. 14, 2020 /CNW/ - AmWolf Capital Corp.
("AmWolf" or the "Company") (TSXV: AMW.P) a
capital pool company ("CPC") as defined under Policy 2.4 –
Capital Pool Companies ("Policy 2.4") of the TSX
Venture Exchange (the "Exchange"), is pleased to announce
that, further to its news release dated November 21, 2019, AmWolf, 1253044 B.C. Ltd., a wholly-owned subsidiary of
AmWolf ("NewCo"), and Pontus Water Lentils Ltd.
("Pontus"), a private company incorporated under
the Canada Business
Corporations Act, have entered into an amalgamation agreement
dated July 28, 2020 (the "Amalgamation
Agreement"), pursuant to which AmWolf will acquire all of the
issued and outstanding common shares (each, a "Pontus Share") of Pontus (the
"Transaction").
The Transaction is subject to the approval of the Exchange, and
is intended to constitute the Company's Qualifying Transaction (as
defined in Policy 2.4). The combined company that will result from
the completion of the Transaction (the "Resulting Issuer")
will be renamed "Pontus Water Lentils Ltd." or such other name as
agreed to by AmWolf and Pontus. Subject to Exchange approval, the
common shares of the Resulting Issuer will trade on the Exchange,
under the symbol "HULK", and the business of the Resulting Issuer
will be the business of Pontus. It is expected that the Resulting
Issuer will be listed on the Exchange as a Tier 2 Industrial
issuer.
Pontus Water Lentils Ltd.
Pontus was founded in 2018, and is a British Columbia-based agri-tech company whose
primary objective is to deliver new sources of organic plant-based
protein products. Pontus specializes in aquaponic farming through
the employment of its proprietary Closed Environment Vertical
Aquaponics System™ or CEVAS™ system, a network of automated
bio-secure indoor aquaponic farms utilizing AI, to produce a
sustainable, non-GMO, organic plant-based protein product called
"Pontus Protein Power+". Pontus' Protein Power+ protein powder is a
42.1% pure plant protein produced from water lentils, high in
antioxidants, essential vitamins and minerals, grown without the
use of solvents, chemicals, dyes, additives, preservatives or
pesticides.
To facilitate the production and processing of its Pontus
Protein Power+ protein powder, Pontus intends to construct a 10,000
sq/ft. processing farm in Delta, British
Columbia (the "Pilot Farm"), where the facility will
utilize Pontus' proprietary CEVAS™. Pontus' Pilot Farm will utilize
the CEVAS™ technology and equipment, an advanced aquaponics system
proprietary to Pontus utilized for the production of its organic
and sustainable water lentils and water lentil protein powder,
Pontus Protein Power+. Following the closing of the Transaction
(the "Closing"), the business of the Resulting Issuer
will be the business of Pontus.
The following table provides select financial information for
Pontus:
|
Three months
ended
February 29,
2020
(Unaudited)
|
November 1,
2018* –
November 30,
2019
(Audited)
|
Total
revenue
|
Nil
|
$
|
Nil
|
Total
assets
|
$
|
696,740
|
$
|
687,500
|
Total
liabilities
|
$
|
303,997
|
$
|
248,731
|
Net income
(loss)
|
$
|
(61,026)
|
$
|
(545,928)
|
*
|
The date of
incorporation of Pontus.
|
Additional financial information with respect to Pontus will be
provided in the filing statement to be filed with the Exchange in
connection with the Transaction.
Summary of the Transaction
The Amalgamation Agreement provides that AmWolf will acquire all
of the issued and outstanding Pontus Shares by way of a
"three-cornered" amalgamation whereby NewCo and Pontus will
amalgamate to form a new amalgamated entity ("AmalCo"), and
Amalco will be a wholly-owned subsidiary of AmWolf. On the Closing,
each of the Pontus Shares will be cancelled and, in consideration
for such Pontus Shares, each Pontus shareholder (collectively, the
"Pontus Shareholders") will receive one (1) common share in
the capital of AmWolf (each, an "AmWolf Share") at a deemed
price of $0.15 per AmWolf Share
for each one (1) Pontus Share held
by such shareholder.
It is expected that, immediately prior to the Closing, there
will be 29,999,999 Pontus Shares issued and outstanding (assuming
completion of the minimum amount of the Pontus Private Placement
(as defined below)) and, accordingly, an aggregate of 29,999,999
AmWolf Shares (each, a "Consideration Share") are expected
to be issued at a deemed price of $0.15 per Consideration Share. AmWolf intends to
rely on Section 2.11 of National Instrument 45-106 – Prospectus
Exemptions for an exemption from the prospectus requirements
for the issuance of the Consideration Shares to the Pontus
Shareholders. The aggregate deemed value of the Consideration
Shares to be issued to the Pontus Shareholders is $4,500,000.
Assuming the completion of the Transaction, the minimum
subscription of the Concurrent Financings (as defined below), and
that no convertible securities of AmWolf or Pontus are exercised, a
minimum of 47,050,000 common shares of the Resulting Issuer (each,
a "Resulting Issuer Share") are expected to be issued
and outstanding on the Closing, of which approximately 63.76% will
be held by the former Pontus Shareholders.
In connection with the Transaction, the Company intends to issue
up to an aggregate of 1,550,000 AmWolf Shares (each, a "Finder's
Share") at a deemed price of $0.15 per Finder's Share to certain eligible
finders, both of whom are arm's length parties to the Company, as a
transaction finder's fee payable in connection with the Transaction
concurrent to the Closing. Excluding those Pontus Shares issued
under the Pontus Private Placement, the measurable benefit of the
Transaction to the Company is based on the anticipated 26,666,666
Consideration Shares to be issued to the Pontus Shareholders at a
deemed price of $0.15 per
Consideration Share for an aggregate total of $4,000,000.
The completion of the Transaction is subject to the satisfaction
of various conditions standard for a transaction of this nature,
including but not limited to: (i) the Company having had the
reasonable opportunity to perform searches and other due diligence,
and being satisfied with the results of such due diligence; (ii)
receipt of all necessary regulatory, shareholder and third party
consents, waivers and approvals, including the Exchange; (iii) the
absence of any material adverse change in the business, affairs or
operations of AmWolf or Pontus, as applicable; and (iv) completion
of the Concurrent Financings.
The Transaction is an arm's length transaction and therefore
will not require the approval of the shareholders of AmWolf under
Policy 2.4.
AmWolf Private Placement and Pontus Private Placement
In connection with the Transaction, the Company anticipates
completing a non-brokered private placement of at least 10,000,000
units (each, an "AmWolf Unit"), up to a maximum of
26,666,666 AmWolf Units, at a price of $0.15 per AmWolf Unit to raise gross proceeds of
$1,500,000 to $4,000,000 (the "AmWolf Private
Placement"). Each AmWolf Unit will consist of one common share
of the Company (each, an "AmWolf Share") and one AmWolf
Share purchase warrant of the Company (each, an "AmWolf
Warrant"). Each AmWolf Warrant will entitle the holder thereof
to purchase one additional common share of the Company (each, an
"AmWolf Warrant Share") at an exercise price of $0.30 per AmWolf Warrant Share for a period of
two years from the date of closing, subject to the Acceleration
Provision (as defined below).
The AmWolf Private Placement is subject to certain conditions
including, but not limited to, the receipt of all necessary
approvals including the approval of the Exchange. The Company
may pay finder's fees on a portion of the AmWolf Private Placement
of up to 8% in cash and, for those applicable, finder's warrants
equal to 8% of such AmWolf Units placed by the finder, each
finder's warrant exercisable for one AmWolf Share for a term of 2
years at a price of $0.30. The
finder's fees shall be paid in accordance with applicable
securities laws and the policies of the Exchange. The securities to
be issued under the AmWolf Private Placement will have a hold
period of four months and one day from the closing.
Pontus also anticipates completing a non-brokered private
placement (the "Pontus Private Placement") of at least
3,333,333 units (each, a "Pontus Unit"), up to a maximum of
6,666,666 Pontus Units, at a price of $0.15 per Pontus Unit to raise gross proceeds of
at least $500,000 to $1,000,000. Each Pontus Unit will consist of one
Pontus Share and one Pontus Share purchase warrant of Pontus (each, a
"Pontus Warrant"). Each Pontus Warrant will entitle the
holder thereof to purchase one additional common share of Pontus
(each, a "Pontus Warrant Share") at an exercise price
of $0.30 per Pontus Warrant Share for
a period of two years from the date of closing, subject to the
Acceleration Provision. Both Pontus and the Company anticipate
completing their respective private placements prior to, or
concurrently with, the Closing (together, the "Concurrent
Financings").
Both the AmWolf Warrants and Pontus Warrants are subject to the
acceleration provision, whereby the expiry of warrants issued in
connection with the Concurrent Financings may be accelerated in the
event the daily trading price of the AmWolf Shares or Resulting
Issuer Shares, as applicable, equals or exceeds $0.50 on the Exchange (or such other exchange on
which the AmWolf Shares or Resulting Issuer Shares, as applicable,
may be traded) for 20 consecutive trading days after the date that
is four months and one day from the closing of each respective
Concurrent Financing, whereby AmWolf or the Resulting Issuer, as
applicable, may accelerate the expiry date of the warrants by
giving notice via news release to the holders thereof and, in such
case, the warrants will expire on the 30th day after the date on
which the news release is disseminated by AmWolf or the Resulting
Issuer, as applicable (the
"Acceleration Provision").
Pontus may pay finder's fees on a portion of the Pontus Private
Placement of up to 7.5% in cash and, for those applicable, finder's
warrants equal to 7% of such Pontus Units placed by the finder,
each finder's warrant exercisable for one Pontus Share for a term of 5 years at a price of
$0.30. The finder's fees shall be
paid in accordance with applicable securities laws. The securities
to be issued under the Pontus Private Placement will have a hold
period expiring on the later of (i) four months and one day from
the closing or (ii) the date on which Pontus becomes a reporting
issuer in any province of territory of Canada. Upon consummation of the Transaction,
all AmWolf Shares issued in exchange for those Pontus Shares issued
under the Pontus Private Placement will be free trading.
Conversely, it is anticipated that following Closing an aggregate
of 11,099,999 Consideration Shares to be issued to 41 Pontus
Shareholders will be subject to certain seed share resale
restrictions as set forth in Section 10 of TSXV Policy 5.4 –
Escrow, Vendor Consideration and Resale Restrictions and an
aggregate of 13,719,001 Consideration Shares held by Principals (as
defined in TSXV Policy 1.1 – Interpretation) of the
Resulting Issuer will be held in escrow pursuant to a value
security escrow agreement based on TSXV Form 5D – Escrow
Agreement.
Proceeds from the Concurrent Financings will be used (i) to
advance the Resulting Issuer's Pilot Farm, (ii) to make
payments related to the completion of the Transaction, (iii) for
general and administrative expenses, and (iv) to contribute to
working capital.
The securities described herein have not been, and will not be,
registered under the United States
Securities Act of 1933, as amended, or any state securities
laws, and accordingly, may not be offered or sold within
the United States absent an
exemption from registration.
Directors, Officers and Insiders of the Resulting
Issuer
Following the Closing, it is expected that the following
individuals will be appointed as management of the Resulting
Issuer:
Connor Yuen, Chief Executive
Officer and Director
Prior to his appointment as Chief Executive Officer
("CEO") of Pontus, Connor
Yuen climbed to the top 1% of executives representing Amway
Corporation, where he maintained that position for 7 years.
Following his time with Amway Corporation, Mr. Yuen has taken his
sales aptitude and shifted his focus to understanding the
securities and capital markets industry. Mr. Yuen was also
Co-Founder of Planet Preservation Vancouver, a not-for-profit
organization that provided free pick-up services of recyclable
items in Vancouver's lower
mainland.
Steve McArthur, Chief
Technology Officer and Director
Steve McArthur is experienced
with aquaponic systems design and facility operations, and has
dedicated himself to the future of farming through this technology.
Mr. McArthur co-founded Pontus, Garden City Aquaponics Inc., and
Green Oasis, and is currently working towards a degree in
engineering at the University of
Victoria. Mr. McArthur has also attended aquaponic training
with Nelson & Pade, Inc., NOA Fisheries, Green'n Aquaponic
Farms, You Grow Food, helped develop Metchosin Acquaponics, and
taken informative tours at Perfect Plants (Netherlands), Taste of BC Farms, Sunshine
Coast Aquaponics, Raincoast Aquaponics, Devon Nurseries, and Mason
St. Farms.
Jeremy Wright – Chief
Financial Officer, Corporate Secretary and Director
Jeremy Wright has been the Chief
Financial Officer ("CFO"), Corporate Secretary and a
Director of the Company since April
2018. Mr. Wright has broad experience working with senior
management developing strategies and solutions to business issues
mainly related to corporate finance, cost and risk management, and
governance which will serve invaluable in his role as a director of
the Resulting Issuer. Mr. Wright is a Chartered Professional
Accountant (Certified Management Accountant), currently serves as
President and CEO of Seatrend Strategy Group and as a director for
several public and private companies including: Centurion Minerals
Ltd., Demetra Minerals Inc. and Freeform Capital Partners Inc. Mr.
Wright previously served as a Director of Pacific Community
Resources Society and the Canadian Freestyle Ski Association. In
addition, Mr. Wright also serves as the CFO for several public and
private companies including: Portofino Resources Inc., Centurion
Minerals Ltd., and Freeform Capital Partners Inc. He was previously
the CFO for GTEC Holdings, a vertically integrated ultra-premium
cannabis producer having 3 operating licensed producers across
Canada. Mr. Wright holds a
Bachelor of Arts, with honours in Environmental Economics from
Brock University.
Sean Kingsley –
Director
Sean Kingsley specializes in
corporate development, strategic marketing, investor relations,
advising & raising capital. Mr. Kingsley has a firm
understanding of the financial markets and experience in utilizing
diverse methods for public engagement. Mr. Kingsley has 13 years of
capital markets experience with a focus on creating corporate
profiles, identity and cultures, awareness, education tools,
creating long-term shareholders/stakeholders along with being a
strong public ambassador, advocate, speaker and avid volunteer. At
the Association for Mineral Exploration BC, Mr. Kingsley served as
Chairman of its Communications and Marketing Committee from 2014 to
2018 and remains as Chair to its Mineral Exploration Editorial
Committee. Mr. Kingsley sits on the Executive, Advisory Council
& Finance Committee for the Centre of Training Excellence in
Mining. Mr. Kingsley is currently the Director of Communications of
Crystal Lake Mining Corporation, a Director of The Wonderfilm Media
Corporation, and Interim CEO and Corporate Secretary of Dunbar
Capital Corp.
Spencer Smyl –
Director
Spencer Smyl has over 8 years of
capital markets and entrepreneur experience with his focus on
building and financing start-ups in the technology, cannabis, video
game, esports, entertainment, heath care, and health & wellness
industries of which he has helped raise over $30 million CAD. In that time, he has gained over
7 years of corporate director and management experience with both
private and public companies. He is also the founder and CEO of
Final Stage Entertainment Inc., a content production company with
an academy nominated management team with over 100+ years of
experience in media and entertainment. The company focuses on
original content creation for the Millennial and Generation Z
demographics. Prior to the capital markets, he spent 2 years
working at the Senate of Canada
under the Honorable Senator Larry
Campbell.
Following the Closing, it is expected that each of Connor Yuen and Alson
Niu will hold, both directly and indirectly, more than 10%
of the Resulting Issuer Shares issued and outstanding and that
Jeremy Wright will hold an aggregate
of 201,667 Resulting Issuer Shares (including 1,667 Resulting
Issuer Shares issued in exchange for Pontus Shares purchased in
connection with the Pontus Private Placement). Alson Niu is a business consultant with several
years of experience specializing in marketing, branding, and
private equity. Mr. Nui co-founded Tracer Digital, a Vancouver marketing solutions company and acts
as the director of corporate communications for Evolve Branding.
More recently, Mr. Niu has applied his broad-based consulting
experience to disrupt the venture capital and private equity arena
as Managing Partner of Vancouver-based Conquest Capital. Aside
from the 1,667 Pontus Shares currently held by Jeremy Wright, there are no other non-arm's
length parties to AmWolf that hold a direct or indirect beneficial
interest in, or are otherwise insiders of, Pontus. Except as
disclosed herein, there is no relationship between or among the
non-arm's length parties to AmWolf and the non-arm's length parties
to the Qualifying Transaction.
Sponsorship
Sponsorship of a Qualifying Transaction of a CPC is required by
the Exchange unless an exemption from the sponsorship requirement
is available. The Company intends to apply for a waiver from the
sponsorship requirements. There is no assurance that the Company
will be able to obtain such a waiver.
About AmWolf Capital Corp.
AmWolf Capital Corp. is a CPC as defined by the policies of the
Exchange. The Company's principal business activity is to identify
and evaluate opportunities for acquisition of assets or business.
The Company is headquartered in Vancouver, British Columbia.
About Pontus Water Lentils Ltd.
Pontus Water Lentils Ltd. was founded in 2018, and is a
British Columbia-based agri-tech
company. Pontus specializes in aquaponic farming through
Closed Environment Vertical Aquaponics System™ or CEVAS™ system to
create a sustainable, non-GMO plant-based protein product: "Pontus
Protein Power+". For more information, visit
www.pontuswaterlentils.com.
Additional Information
All information contained in this news release with respect to
AmWolf and Pontus (each, a "Party" and together, the
"Parties") was supplied, for inclusion herein, by each
respective Party and each Party and its directors and officers have
relied on the other Party for any information concerning the other
Party.
Completion of the Transaction is subject to a number of
conditions, including but not limited to, Exchange acceptance and
if applicable pursuant to Exchange Requirements, majority of the
minority shareholder approval. Where applicable, the Transaction
cannot close until the required shareholder approval is obtained.
There can be no assurance that the Transaction will be completed as
proposed or at all.
Investors are cautioned that, except as disclosed in the
management information circular or filing statement to be prepared
in connection with the Transaction, any information released or
received with respect to the Transaction may not be accurate or
complete and should not be relied upon. Trading in the securities
of a CPC should be considered highly speculative.
The TSX Venture Exchange Inc. has in no way passed upon the
merits of the proposed Transaction and has neither approved nor
disapproved the contents of this press release.
Disclaimer for Forward-Looking Information
Certain statements in this news release are forward-looking
statements, which reflect the expectations of management regarding
the Company's completion of the Transaction and related
transactions. Forward-looking statements consist of statements that
are not purely historical, including any statements regarding
beliefs, plans, expectations or intentions regarding the future,
including but not limited to, the Company completing the
Transaction on the terms and conditions of the Amalgamation
Agreement, or at all, the completion of the Concurrent Financings,
the construction of the proposed Pilot Farm by Pontus, the proposed
directors and officers of the Resulting Issuer and the conditions
to be satisfied for completion of the Transaction. Such statements
are subject to risks and uncertainties that may cause actual
results, performance or developments to differ materially from
those contained in the statements, including risks related to
factors beyond the control of the Company. The risks include the
following: the requisite corporate approvals of the directors and
shareholders of the Parties may not be obtained; the Exchange may
not approve the Transaction; sufficient funds may not be raised
pursuant to the Concurrent Financings; and other risks that are
customary to transactions of this nature. No assurance can be given
that any of the events anticipated by the forward-looking
statements will occur or, if they do occur, what benefits the
Company will obtain from them.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in policies
of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.
SOURCE AmWolf Capital Corp.